We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

BIOBASE

The BIOBASE Group focuses on the development, production and management of scientific equipment, in vitro diagnosis (... read more Featured Products: More products

Download Mobile App





BIOBASE Displays Range Of Laboratory & Medical Analyzers

By LabMedica International staff writers
Posted on 07 Feb 2018
Medical and laboratory products manufacturer, BIOBASE (Jinan, China), showcased its wide range of laboratory & medical analyzers at MEDLAB 2018 held from February 5-8, 2018 in Dubai, UAE. More...
The three-day event saw companies displaying their latest innovations, products and cutting-edge technologies in the IVD, medical laboratory and healthcare market.
 
The BIOBASE Group specializes in eight products areas, including medical diagnosis, biosafety protection, disinfection and sterilization, water purification system, infant care products, cold chain products, software products, and clean room project. The company has obtained patents and expanded marketing for multiple products, such as the self-developed biochemistry analyzer, 107 kinds of reagents, automatic ELISA processor, medical sterilization instruments and biosafety protection equipment. 
 
After participating successfully in the global medical trade show Arab Health 2018 held in Dubai just last week, BIOBASE once again exhibited its product range of chemistry analyzers, auto ELISA processor, hematology analyzers, coagulation analyzers, ESR analyzers, ELISA microplate readers, medical refrigerators and biological safety cabinets at MEDLAB Middle East 2018. The company also displayed other products such as fume hood, autoclaves, microscopes, incubators and reagents at the event.
 

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Prefilled Tubes
Prefilled 5.0ml Tubes
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: The “broth” used to monitor red blood cell depletion in whole blood spiked with one colony-forming-unit of E. coli bacteria, each incubated at different orbital shaking speeds—left to right: 0 RPM, 65 RPM, 120 RPM and 200 RPM—after four hours of incubation. This culturing raises a bacteria-rich, plasma-like layer of bacteria to the top of the vials, while clusters of stuck blood cells known as a Rouleaux formation sink to the bottom. (Image Credit: Pak Kin Wong)

New Diagnostic Workflow Identifies Bloodstream Pathogens and Antibiotic Response in Hours

Sepsis is a life-threatening complication of infection that affects more than 1.5 million patients annually in the United States and contributes to roughly one in three in-hospital deaths.... Read more

Pathology

view channel
Image: Researchers evaluated AI models that quantify tumor-infiltrating lymphocytes (TIL) on routine breast tissue slides, where higher TIL levels reflect stronger antitumor response and improved breast cancer outcomes (Image Credit: Shutterstock)

AI Matches Pathologists in Predicting Breast Cancer Prognosis from Immune Cells

Breast cancer is the most common cancer in Australian women, with more than 20,000 cases each year. Prognosis can be informed by counting tumor-infiltrating lymphocytes (TILs) on routine pathology slides,... Read more

Industry

view channel
Image Credit: Adobe Stock

Companion Diagnostics Expand HER2 Testing in Metastatic Gastroesophageal Cancer

Gastroesophageal adenocarcinoma comprises a group of aggressive cancers that are often diagnosed at an advanced stage and carry poor prognoses. Gastric and esophageal cancers rank among the leading causes... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.